Copyright Reports & Markets. All rights reserved.

Global Colorectal Cancer Drugs Sales Market Report 2021

Request for Sample of this report
Buy now

1 Colorectal Cancer Drugs Market Overview

  • 1.1 Colorectal Cancer Drugs Product Scope
  • 1.2 Colorectal Cancer Drugs Segment
    • 1.2.1 Global Colorectal Cancer Drugs Sales (2016 & 2021 & 2027)
    • 1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
    • 1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
    • 1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
    • 1.2.5 BRAF or MEK Inhibitors
    • 1.2.6 Tyrosine Kinase (TKI) Inhibitors
    • 1.2.7 Immunomodulators
  • 1.3 Colorectal Cancer Drugs Segment
    • 1.3.1 Global Colorectal Cancer Drugs Sales Comparison (2016 & 2021 & 2027)
    • 1.3.2 Radiotherapy
    • 1.3.3 Chemotherapy
  • 1.4 Colorectal Cancer Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Colorectal Cancer Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Colorectal Cancer Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Colorectal Cancer Drugs Price Trends (2016-2027)

2 Colorectal Cancer Drugs Estimates and Forecasts by Region

  • 2.1 Global Colorectal Cancer Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Colorectal Cancer Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Colorectal Cancer Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Colorectal Cancer Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Colorectal Cancer Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Colorectal Cancer Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Colorectal Cancer Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Colorectal Cancer Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Colorectal Cancer Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Colorectal Cancer Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Colorectal Cancer Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Colorectal Cancer Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Colorectal Cancer Drugs Estimates and Projections (2016-2027)

3 Global Colorectal Cancer Drugs Competition Landscape by Players

  • 3.1 Global Top Colorectal Cancer Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Colorectal Cancer Drugs Players by Revenue (2016-2021)
  • 3.3 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2020)
  • 3.4 Global Colorectal Cancer Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Colorectal Cancer Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Colorectal Cancer Drugs Market Size

  • 4.1 Global Colorectal Cancer Drugs Historic Market Review (2016-2021)
    • 4.1.1 Global Colorectal Cancer Drugs Sales Market Share (2016-2021)
    • 4.1.2 Global Colorectal Cancer Drugs Revenue Market Share (2016-2021)
    • 4.1.3 Global Colorectal Cancer Drugs Price (2016-2021)
  • 4.2 Global Colorectal Cancer Drugs Market Estimates and Forecasts (2022-2027)
    • 4.2.1 Global Colorectal Cancer Drugs Sales Forecast (2022-2027)
    • 4.2.2 Global Colorectal Cancer Drugs Revenue Forecast (2022-2027)
    • 4.2.3 Global Colorectal Cancer Drugs Price Forecast (2022-2027)

5 Global Colorectal Cancer Drugs Market Size

  • 5.1 Global Colorectal Cancer Drugs Historic Market Review (2016-2021)
    • 5.1.1 Global Colorectal Cancer Drugs Sales Market Share (2016-2021)
    • 5.1.2 Global Colorectal Cancer Drugs Revenue Market Share (2016-2021)
    • 5.1.3 Global Colorectal Cancer Drugs Price (2016-2021)
  • 5.2 Global Colorectal Cancer Drugs Market Estimates and Forecasts (2022-2027)
    • 5.2.1 Global Colorectal Cancer Drugs Sales Forecast (2022-2027)
    • 5.2.2 Global Colorectal Cancer Drugs Revenue Forecast (2022-2027)
    • 5.2.3 Global Colorectal Cancer Drugs Price Forecast (2022-2027)

6 North America Colorectal Cancer Drugs Market Facts & Figures

  • 6.1 North America Colorectal Cancer Drugs Sales by Company
    • 6.1.1 North America Colorectal Cancer Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Colorectal Cancer Drugs Revenue by Company (2016-2021)
  • 6.2 North America Colorectal Cancer Drugs Sales Breakdown
    • 6.2.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 6.2.2 North America Colorectal Cancer Drugs Sales Breakdown (2022-2027)
  • 6.3 North America Colorectal Cancer Drugs Sales Breakdown
    • 6.3.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 6.3.2 North America Colorectal Cancer Drugs Sales Breakdown (2022-2027)

7 Europe Colorectal Cancer Drugs Market Facts & Figures

  • 7.1 Europe Colorectal Cancer Drugs Sales by Company
    • 7.1.1 Europe Colorectal Cancer Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Colorectal Cancer Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Colorectal Cancer Drugs Sales Breakdown
    • 7.2.1 Europe Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 7.2.2 Europe Colorectal Cancer Drugs Sales Breakdown (2022-2027)
  • 7.3 Europe Colorectal Cancer Drugs Sales Breakdown
    • 7.3.1 Europe 144 Sales Breakdown (2016-2021)
    • 7.3.2 Europe 144 Sales Breakdown (2022-2027)

8 China Colorectal Cancer Drugs Market Facts & Figures

  • 8.1 China Colorectal Cancer Drugs Sales by Company
    • 8.1.1 China Colorectal Cancer Drugs Sales by Company (2016-2021)
    • 8.1.2 China Colorectal Cancer Drugs Revenue by Company (2016-2021)
  • 8.2 China Colorectal Cancer Drugs Sales Breakdown
    • 8.2.1 China Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 8.2.2 China Colorectal Cancer Drugs Sales Breakdown (2022-2027)
  • 8.3 China Colorectal Cancer Drugs Sales Breakdown
    • 8.3.1 China 311 Sales Breakdown (2016-2021)
    • 8.3.2 China 311 Sales Breakdown (2022-2027)

9 Japan Colorectal Cancer Drugs Market Facts & Figures

  • 9.1 Japan Colorectal Cancer Drugs Sales by Company
    • 9.1.1 Japan Colorectal Cancer Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Colorectal Cancer Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Colorectal Cancer Drugs Sales Breakdown
    • 9.2.1 Japan Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 9.2.2 Japan Colorectal Cancer Drugs Sales Breakdown (2022-2027)
  • 9.3 Japan Colorectal Cancer Drugs Sales Breakdown
    • 9.3.1 Japan Feb. Sales Breakdown (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown (2022-2027)

10 Southeast Asia Colorectal Cancer Drugs Market Facts & Figures

  • 10.1 Southeast Asia Colorectal Cancer Drugs Sales by Company
    • 10.1.1 Southeast Asia Colorectal Cancer Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Colorectal Cancer Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Colorectal Cancer Drugs Sales Breakdown
    • 10.2.1 Southeast Asia Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 10.2.2 Southeast Asia Colorectal Cancer Drugs Sales Breakdown (2022-2027)
  • 10.3 Southeast Asia Colorectal Cancer Drugs Sales Breakdown
    • 10.3.1 Southeast Asia MT Sales Breakdown (2016-2021)
    • 10.3.2 Southeast Asia MT Sales Breakdown (2022-2027)

11 India Colorectal Cancer Drugs Market Facts & Figures

  • 11.1 India Colorectal Cancer Drugs Sales by Company
    • 11.1.1 India Colorectal Cancer Drugs Sales by Company (2016-2021)
    • 11.1.2 India Colorectal Cancer Drugs Revenue by Company (2016-2021)
  • 11.2 India Colorectal Cancer Drugs Sales Breakdown
    • 11.2.1 India Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 11.2.2 India Colorectal Cancer Drugs Sales Breakdown (2022-2027)
  • 11.3 India Colorectal Cancer Drugs Sales Breakdown
    • 11.3.1 India Colorectal Cancer Drugs Sales Breakdown (2016-2021)
    • 11.3.2 India Colorectal Cancer Drugs Sales Breakdown (2022-2027)

12 Company Profiles and Key Figures in Colorectal Cancer Drugs Business

  • 12.1 AB Science
    • 12.1.1 AB Science Corporation Information
    • 12.1.2 AB Science Business Overview
    • 12.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 AB Science Colorectal Cancer Drugs Products Offered
    • 12.1.5 AB Science Recent Development
  • 12.2 Amgen
    • 12.2.1 Amgen Corporation Information
    • 12.2.2 Amgen Business Overview
    • 12.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Amgen Colorectal Cancer Drugs Products Offered
    • 12.2.5 Amgen Recent Development
  • 12.3 Array BioPharma
    • 12.3.1 Array BioPharma Corporation Information
    • 12.3.2 Array BioPharma Business Overview
    • 12.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
    • 12.3.5 Array BioPharma Recent Development
  • 12.4 Bayer
    • 12.4.1 Bayer Corporation Information
    • 12.4.2 Bayer Business Overview
    • 12.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Bayer Colorectal Cancer Drugs Products Offered
    • 12.4.5 Bayer Recent Development
  • 12.5 Boehringer Ingelheim
    • 12.5.1 Boehringer Ingelheim Corporation Information
    • 12.5.2 Boehringer Ingelheim Business Overview
    • 12.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
    • 12.5.5 Boehringer Ingelheim Recent Development
  • 12.6 Bristol-Myers Squibb
    • 12.6.1 Bristol-Myers Squibb Corporation Information
    • 12.6.2 Bristol-Myers Squibb Business Overview
    • 12.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
    • 12.6.5 Bristol-Myers Squibb Recent Development
  • 12.7 Elli Lilly
    • 12.7.1 Elli Lilly Corporation Information
    • 12.7.2 Elli Lilly Business Overview
    • 12.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
    • 12.7.5 Elli Lilly Recent Development
  • 12.8 Roch
    • 12.8.1 Roch Corporation Information
    • 12.8.2 Roch Business Overview
    • 12.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Roch Colorectal Cancer Drugs Products Offered
    • 12.8.5 Roch Recent Development
  • 12.9 Hutchison MediPharma
    • 12.9.1 Hutchison MediPharma Corporation Information
    • 12.9.2 Hutchison MediPharma Business Overview
    • 12.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
    • 12.9.5 Hutchison MediPharma Recent Development
  • 12.10 Merck & Co., Inc.
    • 12.10.1 Merck & Co., Inc. Corporation Information
    • 12.10.2 Merck & Co., Inc. Business Overview
    • 12.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
    • 12.10.5 Merck & Co., Inc. Recent Development
  • 12.11 Mologen
    • 12.11.1 Mologen Corporation Information
    • 12.11.2 Mologen Business Overview
    • 12.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Mologen Colorectal Cancer Drugs Products Offered
    • 12.11.5 Mologen Recent Development
  • 12.12 Regeneron
    • 12.12.1 Regeneron Corporation Information
    • 12.12.2 Regeneron Business Overview
    • 12.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Regeneron Colorectal Cancer Drugs Products Offered
    • 12.12.5 Regeneron Recent Development
  • 12.13 Sanofi
    • 12.13.1 Sanofi Corporation Information
    • 12.13.2 Sanofi Business Overview
    • 12.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Sanofi Colorectal Cancer Drugs Products Offered
    • 12.13.5 Sanofi Recent Development
  • 12.14 Sumitomo Dainippon
    • 12.14.1 Sumitomo Dainippon Corporation Information
    • 12.14.2 Sumitomo Dainippon Business Overview
    • 12.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Products Offered
    • 12.14.5 Sumitomo Dainippon Recent Development
  • 12.15 Taiho Pharmaceutical
    • 12.15.1 Taiho Pharmaceutical Corporation Information
    • 12.15.2 Taiho Pharmaceutical Business Overview
    • 12.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Products Offered
    • 12.15.5 Taiho Pharmaceutical Recent Development
  • 12.16 Vaccinogen
    • 12.16.1 Vaccinogen Corporation Information
    • 12.16.2 Vaccinogen Business Overview
    • 12.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Vaccinogen Colorectal Cancer Drugs Products Offered
    • 12.16.5 Vaccinogen Recent Development

13 Colorectal Cancer Drugs Manufacturing Cost Analysis

  • 13.1 Colorectal Cancer Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Colorectal Cancer Drugs
  • 13.4 Colorectal Cancer Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Colorectal Cancer Drugs Distributors List
  • 14.3 Colorectal Cancer Drugs Customers

15 Market Dynamics

  • 15.1 Colorectal Cancer Drugs Market Trends
  • 15.2 Colorectal Cancer Drugs Drivers
  • 15.3 Colorectal Cancer Drugs Market Challenges
  • 15.4 Colorectal Cancer Drugs Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Colorectal Cancer Drugs market is segmented by company, region (country), , and . Players, stakeholders, and other participants in the global Colorectal Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), and for the period 2016-2027.

    Segment
    Vascular Endothelial Growth Factor (VEGF) Inhibitors
    Epidermal Growth Factor Receptor (EGFR) Inhibitors
    Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
    BRAF or MEK Inhibitors
    Tyrosine Kinase (TKI) Inhibitors
    Immunomodulators

    Segment
    Radiotherapy
    Chemotherapy

    The Colorectal Cancer Drugs market is analysed and market size information is provided by regions (countries). Segment , the Colorectal Cancer Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    AB Science
    Amgen
    Array BioPharma
    Bayer
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Elli Lilly
    Roch
    Hutchison MediPharma
    Merck & Co., Inc.
    Mologen
    Regeneron
    Sanofi
    Sumitomo Dainippon
    Taiho Pharmaceutical
    Vaccinogen

    Buy now